AXIM Biotechnologies, Inc. (AXIM) stock
AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2024, quý kết thúc ngày Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
AXIM Biotechnologies total assets
Total assets on the balance sheet at the end of each period.
AXIM Biotechnologies's total assets was $3.73M at Jun 30, 2024. For fiscal 2023 it was $4.12M, down 2.1% from the year before. Over ten years it grew 53.5% a year on average. The highest annual figure on record is $11.31M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $4.12M | -2.1% |
| FY2022 | Dec 31, 2022 | $4.21M | -20.9% |
| FY2021 | Dec 31, 2021 | $5.32M | -52.9% |
| FY2020 | Dec 31, 2020 | $11.31M | +568.7% |
| FY2019 | Dec 31, 2019 | $1.69M | -19.0% |
| FY2018 | Dec 31, 2018 | $2.09M | -4.7% |
| FY2017 | Dec 31, 2017 | $2.19M | +51.3% |
| FY2016 | Dec 31, 2016 | $1.45M | +14.9% |
| FY2015 | Dec 31, 2015 | $1.26M | +70.8% |
| FY2014 | Dec 31, 2014 | $738.46K | +1199.6% |
| FY2013 | Dec 31, 2013 | $56.82K | -57.2% |
| FY2012 | Dec 31, 2012 | $132.82K | -3.3% |
| FY2011 | Dec 31, 2011 | $137.31K | – |
| FY2010 | Dec 31, 2010 | $0 | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | $3.73M | -12.2% |
| Q1 FY2024 | Mar 31, 2024 | $3.93M | -2.7% |
| Q4 FY2023 | Dec 31, 2023 | $4.12M | -2.1% |
| Q3 FY2023 | Sep 30, 2023 | $4.04M | -9.7% |
| Q2 FY2023 | Jun 30, 2023 | $4.25M | -6.1% |
| Q1 FY2023 | Mar 31, 2023 | $4.04M | -20.2% |
| Q4 FY2022 | Dec 31, 2022 | $4.21M | -20.9% |
| Q3 FY2022 | Sep 30, 2022 | $4.48M | -68.6% |
| Q2 FY2022 | Jun 30, 2022 | $4.52M | -56.3% |
| Q1 FY2022 | Mar 31, 2022 | $5.06M | -55.1% |
| Q4 FY2021 | Dec 31, 2021 | $5.32M | -52.9% |
| Q3 FY2021 | Sep 30, 2021 | $14.25M | +17.5% |
| Q2 FY2021 | Jun 30, 2021 | $10.35M | -6.5% |
| Q1 FY2021 | Mar 31, 2021 | $11.27M | +3.2% |
| Q4 FY2020 | Dec 31, 2020 | $11.31M | +568.7% |
| Q3 FY2020 | Sep 30, 2020 | $12.13M | +410.3% |
| Q2 FY2020 | Jun 30, 2020 | $11.07M | +284.2% |
| Q1 FY2020 | Mar 31, 2020 | $10.91M | +261.7% |
| Q4 FY2019 | Dec 31, 2019 | $1.69M | -19.0% |
| Q3 FY2019 | Sep 30, 2019 | $2.38M | +200.2% |
| Q2 FY2019 | Jun 30, 2019 | $2.88M | +319.9% |
| Q1 FY2019 | Mar 31, 2019 | $3.02M | +261.7% |
| Q4 FY2018 | Dec 31, 2018 | $2.09M | -4.7% |
| Q3 FY2018 | Sep 30, 2018 | $791.69K | -76.2% |
| Q2 FY2018 | Jun 30, 2018 | $686.30K | -84.5% |
| Q1 FY2018 | Mar 31, 2018 | $834.38K | +1.2% |
| Q4 FY2017 | Dec 31, 2017 | $2.19M | +51.3% |
| Q3 FY2017 | Sep 30, 2017 | $3.32M | +170.0% |
| Q2 FY2017 | Jun 30, 2017 | $4.41M | +817.2% |
| Q1 FY2017 | Mar 31, 2017 | $824.77K | +25.9% |
| Q4 FY2016 | Dec 31, 2016 | $1.45M | +14.9% |
| Q3 FY2016 | Sep 30, 2016 | $1.23M | -32.6% |
| Q2 FY2016 | Jun 30, 2016 | $481.24K | -84.5% |
| Q1 FY2016 | Mar 31, 2016 | $654.90K | +178.0% |
| Q4 FY2015 | Dec 31, 2015 | $1.26M | +70.8% |
| Q3 FY2015 | Sep 30, 2015 | $1.82M | +71.8% |
| Q2 FY2015 | Jun 30, 2015 | $3.10M | – |
| Q1 FY2015 | Mar 31, 2015 | $235.60K | – |
| Q4 FY2014 | Dec 31, 2014 | $738.46K | – |
| Q3 FY2014 | Sep 30, 2014 | $1.06M | – |
See a number that looks wrong?